CoChat

Endometriosis-Associated Macrophages: Origin, Phenotype, and Function

Open access
Hogg, Chloe, Horne, Andrew W., Greaves, Erin · 2020 · Frontiers in Endocrinology
Cited by 238

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Abstract

Endometriosis is a complex, heterogeneous, chronic inflammatory condition impacting ~176 million women worldwide. It is associated with chronic pelvic pain, infertility, and fatigue, and has a substantial impact on health-related quality of life. Endometriosis is defined by the growth of endometrial-like tissue outside the uterus, typically on the lining of the pelvic cavity and ovaries (known as "lesions"). Macrophages are complex cells at the center of this enigmatic condition; they are critical for the growth, development, vascularization, and innervation of lesions as well as generation of pain symptoms. In health, tissue-resident macrophages are seeded during early embryonic life are vital for development and homeostasis of tissues. In the adult, under inflammatory challenge, monocytes are recruited from the blood and differentiate into macrophages in tissues where they fulfill functions, such as fighting infection and repairing wounds. The interplay between tissue-resident and recruited macrophages is now at the forefront of macrophage research due to their differential roles in inflammatory disorders. In some cancers, tumor-associated macrophages (TAMs) are comprised of tissue-resident macrophages and recruited inflammatory monocytes that differentiate into macrophages within the tumor. These macrophages of different origins play differential roles in disease progression. Herein, we review the complexities of macrophage dynamics in health and disease and explore the paradigm that under disease-modified conditions, macrophages that normally maintain homeostasis become modified such that they promote disease. We also interrogate the evidence to support the existence of multiple phenotypic populations and origins of macrophages in endometriosis and how this could be exploited for therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fendo.2020.00007

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 96

  1. Mahmood, 1991, Prevalence and genesis of endometriosis, Hum Reprod., 6, 544, 10.1093/oxfordjournals.humrep.a137377 · DOI · Paper page
  2. Hansen, 2010, Management of endometriosis-associated pain, Clin Obstet Gynecol., 53, 439, 10.1097/GRF.0b013e3181dbda06 · DOI
  3. Klein, 2014, What is the societal burden of endometriosis-associated symptoms?, Reprod Biomed Online., 28, 116, 10.1016/j.rbmo.2013.09.020 · DOI
  4. Saraswat, 2017, Pregnancy outcomes in women with endometriosis: a national record linkage study, BJOG., 124, 444, 10.1111/1471-0528.13920 · DOI · Paper page
  5. Nnoaham, 2019, Reprint of: impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries, Fertil Steril., 112, e137, 10.1016/j.fertnstert.2019.08.082 · DOI
  6. Bazot, 2017, Diagnosis of deep endometriosis: clinical examination, ultrasonography, magnetic resonance imaging, and other techniques, Fertil Steril., 108, 886, 10.1016/j.fertnstert.2017.10.026 · DOI · Paper page
  7. Bedaiwy, 2017, New developments in the medical treatment of endometriosis, Fertil Steril., 107, 555, 10.1016/j.fertnstert.2016.12.025 · DOI · Paper page
  8. Agarwal, 2019, Rethinking endometriosis care: applying the chronic care model via a multidisciplinary program for the care of women with endometriosis, Int J Womens Health., 11, 405, 10.2147/IJWH.S207373 · DOI
  9. Adamson, 2011, Endometriosis classification: an update, Curr Opin Obstet Gynecol., 23, 213, 10.1097/GCO.0b013e328348a3ba · DOI · Paper page
  10. Malinak, 1980, Heritage aspects of endometriosis. II. Clinical characteristics of familial endometriosis, Am J Obstet Gynecol., 137, 332, 10.1016/0002-9378(80)90918-7 · DOI
  11. Nouri, 2010, Family incidence of endometriosis in first-, second-, and third-degree relatives: case-control study, Reprod Biol Endocrinol., 8, 85, 10.1186/1477-7827-8-85 · DOI
  12. Nnoaham, 2012, Is early age at menarche a risk factor for endometriosis?, Fertil Steril., 98, 702, 10.1016/j.fertnstert.2012.05.035 · DOI · Paper page
  13. Osinski, 2018, HSD3B2, HSD17B1, HSD17B2, ESR1, ESR2 and AR expression in infertile women with endometriosis, Ginekol Pol., 89, 125, 10.5603/GP.a2018.0022 · DOI
  14. Liang, 2018, Villainous role of estrogen in macrophage-nerve interaction in endometriosis, Reprod Biol Endocrinol., 16, 122, 10.1186/s12958-018-0441-z · DOI
  15. Halme, 1987, Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis, Am J Obstet Gynecol., 156, 783, 10.1016/0002-9378(87)90333-4 · DOI · Paper page
  16. Tariverdian, 2009, Intraperitoneal immune cell status in infertile women with and without endometriosis, J Reprod Immunol., 80, 80, 10.1016/j.jri.2008.12.005 · DOI
  17. Jeung, 2016, Decreased cytotoxicity of peripheral and peritoneal natural killer cell in endometriosis, BioMed Res Int., 2016, 2916070, 10.1155/2016/2916070 · DOI
  18. Ho, 1995, Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III-IV endometriosis, Hum Reprod., 10, 2671, 10.1093/oxfordjournals.humrep.a135765 · DOI
  19. Wu, 2005, Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis, Am J Pathol., 167, 1061, 10.1016/S0002-9440(10)61195-9 · DOI
  20. Sampson, 1927, Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation, Am J Pathol., 3, 93
  21. Greaves, 2014, A novel mouse model of endometriosis mimics human phenotype and reveals insights into the inflammatory contribution of shed endometrium, Am J Pathol., 184, 1930, 10.1016/j.ajpath.2014.03.011 · DOI · Paper page
  22. Cousins, 2016, Evidence for a dynamic role for mononuclear phagocytes during endometrial repair and remodelling, Sci Rep., 6, 36748, 10.1038/srep36748 · DOI
  23. Troncon, 2014, Endometriosis in a patient with mayer-rokitansky-kuster-hauser syndrome, Case Rep Obstetr Gynecol., 2014, 376231, 10.1155/2014/376231 · DOI
  24. Jablonski, 2009, Pneumoperitoneum associated with catamenial pneumothorax in women with thoracic endometriosis, Fertil Steril., 91, 930.e19, 10.1016/j.fertnstert.2008.09.071 · DOI
  25. Martin, 1985, Endometriosis in the male, Am Surg., 51, 426
  26. Abomaray, 2017, Mesenchymal stromal cells are more immunosuppressive in vitro if they are derived from endometriotic lesions than from eutopic endometrium, Stem Cells Int., 2017, 3215962, 10.1155/2017/3215962 · DOI
  27. Batt, 2013, Mullerianosis: four developmental (embryonic) mullerian diseases, Reprod Sci., 20, 1030, 10.1177/1933719112472736 · DOI
  28. Forster, 2019, Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis, FASEB J., 33, 11210, 10.1096/fj.201900797R · DOI · Paper page
  29. Lloyd, 2016, Cellular and molecular mechanisms underpinning macrophage activation during remyelination, Front Cell Dev Biol., 4, 60, 10.3389/fcell.2016.00060 · DOI
  30. Geissmann, 2010, Development of monocytes, macrophages, and dendritic cells, Science., 327, 656, 10.1126/science.1178331 · DOI · Paper page
  31. Olingy, 2017, Non-classical monocytes are biased progenitors of wound healing macrophages during soft tissue injury, Sci Rep., 7, 447, 10.1038/s41598-017-00477-1 · DOI · Paper page
  32. Jakubzick, 2013, Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes, Immunity., 39, 599, 10.1016/j.immuni.2013.08.007 · DOI · Paper page
  33. Randolph, 2009, The fate of monocytes in atherosclerosis, J Thromb Haemost., 7, 28, 10.1111/j.1538-7836.2009.03423.x · DOI
  34. Ingersoll, 2010, Comparison of gene expression profiles between human and mouse monocyte subsets, Blood., 115, e10, 10.1182/blood-2009-07-235028 · DOI · Paper page
  35. Rey-Giraud, 2012, In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions, PLoS ONE., 7, e42656, 10.1371/journal.pone.0042656 · DOI · Paper page
  36. Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell., 141, 39, 10.1016/j.cell.2010.03.014 · DOI · Paper page
  37. Udalova, 2016, Macrophage heterogeneity in the context of rheumatoid arthritis, Nat Rev Rheumatol., 12, 472, 10.1038/nrrheum.2016.91 · DOI · Paper page
  38. Arici, 1995, Regulation of monocyte chemotactic protein-1 gene expression in human endometrial cells in cultures, Mol Cell Endocrinol., 107, 189, 10.1016/0303-7207(94)03442-V · DOI
  39. Jones, 1997, Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation, Hum Reprod., 12, 1300, 10.1093/humrep/12.6.1300 · DOI · Paper page
  40. Kitaya, 2004, Spatial and temporal expression of ligands for CXCR3 and CXCR4 in human endometrium, J Clin Endocrinol Metab., 89, 2470, 10.1210/jc.2003-031293 · DOI
  41. Eidukaite, 2004, Endometrial and peritoneal macrophages: expression of activation and adhesion molecules, Am J Reprod Immunol., 52, 113, 10.1111/j.1600-0897.2004.00201.x · DOI
  42. Garry, 2010, Structural changes in endometrial basal glands during menstruation, BJOG., 117, 1175, 10.1111/j.1471-0528.2010.02630.x · DOI · Paper page
  43. Sharkey, 2000, Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia, J Clin Endocrinol Metab., 85, 402, 10.1210/jc.85.1.402 · DOI · Paper page
  44. Zhang, 2005, The role and regulation of the uterine matrix metalloproteinase system in menstruating and non-menstruating species, Front Biosci., 10, 353, 10.2741/1533 · DOI
  45. Curry, 2003, The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle, Endocr Rev., 24, 428, 10.1210/er.2002-0005 · DOI · Paper page
  46. Jeziorska, 1996, Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle, J Reprod Fertil., 107, 43, 10.1530/jrf.0.1070043 · DOI
  47. McLaren, 1996, Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids, J Clin Invest., 98, 482, 10.1172/JCI118815 · DOI · Paper page
  48. Rochefort, 2001, Estrogen regulated proteases and antiproteases in ovarian and breast cancer cells, J Steroid Biochem Mol Biol., 76, 119, 10.1016/S0960-0760(00)00142-4 · doi:10.1016/s0960-0760(00)00142-4
  49. Stewart, 1998, Endometrial leucocytes: expression of steroid hormone receptors, J Clin Pathol., 51, 121, 10.1136/jcp.51.2.121 · DOI · Paper page
  50. Cheng, 2007, Quantitative cellular and molecular analysis of the effect of progesterone withdrawal in a murine model of decidualization, Biol Reprod., 76, 871, 10.1095/biolreprod.106.057950 · DOI
  51. Thiruchelvam, 2016, Cortisol regulates the paracrine action of macrophages by inducing vasoactive gene expression in endometrial cells, J Leukoc Biol., 99, 1165, 10.1189/jlb.5A0215-061RR · DOI
  52. Jackson-Jones, 2018, Control of innate-like B cell location for compartmentalised IgM production, Curr Opin Immunol., 50, 9, 10.1016/j.coi.2017.10.006 · DOI
  53. Rosas, 2014, The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal, Science., 344, 645, 10.1126/science.1251414 · DOI · Paper page
  54. Kubicka, 1996, Normal human immune peritoneal cells: subpopulations and functional characteristics, Scand J Immunol., 44, 157, 10.1046/j.1365-3083.1996.d01-297.x · DOI
  55. Irvine, 2016, CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascites, JCI Insight., 1, e86914, 10.1172/jci.insight.86914 · DOI
  56. Barth, 1995, Review of the macrophage disappearance reaction, J Leukoc Biol., 57, 361, 10.1002/jlb.57.3.361 · DOI · Paper page
  57. Davies, 2011, A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation, Eur J Immunol., 41, 2155, 10.1002/eji.201141817 · DOI · Paper page
  58. Gautier, 2013, Local apoptosis mediates clearance of macrophages from resolving inflammation in mice, Blood., 122, 2714, 10.1182/blood-2013-01-478206 · DOI · Paper page
  59. Liao, 2016, IL-10 differentially controls the infiltration of inflammatory macrophages and antigen-presenting cells during inflammation, Eur J Immunol., 46, 2222, 10.1002/eji.201646528 · DOI
  60. Wong, 2010, Phosphatidylserine receptor Tim-4 is essential for the maintenance of the homeostatic state of resident peritoneal macrophages, Proc Natl Acad Sci USA., 107, 8712, 10.1073/pnas.0910929107 · DOI · Paper page
  61. Ruckerl, 2017, Macrophage origin limits functional plasticity in helminth-bacterial co-infection, PLoS Pathog., 13, e1006233, 10.1371/journal.ppat.1006233 · DOI
  62. Cassado Ados, 2011, Cellular renewal and improvement of local cell effector activity in peritoneal cavity in response to infectious stimuli, PLoS ONE., 6, e22141, 10.1371/journal.pone.0022141 · DOI
  63. Bellingan, 1996, In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes, J Immunol., 157, 2577, 10.4049/jimmunol.157.6.2577 · DOI · Paper page
  64. Bain, 2018, The biology of serous cavity macrophages, Cell Immunol., 330, 126, 10.1016/j.cellimm.2018.01.003 · DOI
  65. Burnett, 2006, Development of peritoneal adhesions in macrophage depleted mice, J Surg Res., 131, 296, 10.1016/j.jss.2005.08.026 · DOI
  66. Wang, 2019, The origin and pathogenesis of endometriosis, Annu Rev Pathol., 10.1146/annurev-pathmechdis-012419-032654 · DOI · Paper page
  67. Zhang, 2012, Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature, PLoS ONE., 7, e50946, 10.1371/journal.pone.0050946 · DOI · Paper page
  68. Sawanobori, 2008, Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice, Blood., 111, 5457, 10.1182/blood-2008-01-136895 · DOI · Paper page
  69. Cortez-Retamozo, 2012, Origins of tumor-associated macrophages and neutrophils, Proc Natl Acad Sci USA., 109, 2491, 10.1073/pnas.1113744109 · DOI · Paper page
  70. Yang, 2012, Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs), J Biol Chem., 287, 40140, 10.1074/jbc.M112.348763 · DOI
  71. Sekiguchi, 2019, VEGF receptor 1-expressing macrophages recruited from bone marrow enhances angiogenesis in endometrial tissues, Sci Rep., 9, 7037, 10.1038/s41598-019-43185-8 · DOI
  72. Hey, 2015, Redefining myeloid cell subsets in murine spleen, Front Immunol., 6, 652, 10.3389/fimmu.2015.00652 · DOI
  73. Capobianco, 2011, Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease, Am J Pathol., 179, 2651, 10.1016/j.ajpath.2011.07.029 · DOI
  74. Berbic, 2009, Macrophage expression in endometrium of women with and without endometriosis, Hum Reprod., 24, 325, 10.1093/humrep/den393 · DOI · Paper page
  75. Takebayashi, 2015, Subpopulations of macrophages within eutopic endometrium of endometriosis patients, Am J Reprod Immunol., 73, 221, 10.1111/aji.12331 · DOI · Paper page
  76. Jolicoeur, 1998, Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis, Am J Pathol., 152, 125
  77. Collette, 2006, Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis, Hum Reprod., 21, 3059, 10.1093/humrep/del297 · DOI
  78. Yang, 2017, The crosstalk between endometrial stromal cells and macrophages impairs cytotoxicity of NK cells in endometriosis by secreting IL-10 and TGF-beta, Reproduction., 154, 815, 10.1530/REP-17-0342 · DOI
  79. Beste, 2014, Molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation, Sci Transl Med., 6, 222ra16, 10.1126/scitranslmed.3007988 · DOI · Paper page
  80. Fan, 2018, Expression of inflammatory cytokines in serum and peritoneal fluid from patients with different stages of endometriosis, Gynecol Endocrinol., 34, 507, 10.1080/09513590.2017.1409717 · DOI
  81. Yuan, 2017, Rediscovering peritoneal macrophages in a murine endometriosis model, Hum Reprod., 32, 94, 10.1093/humrep/dew274 · DOI
  82. Johan, 2019, Macrophages infiltrating endometriosis-like lesions exhibit progressive phenotype changes in a heterologous mouse model, J Reprod Immunol., 132, 1, 10.1016/j.jri.2019.01.002 · DOI
  83. Van Rooijen, 1994, Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications, J Immunol Methods., 174, 83, 10.1016/0022-1759(94)90012-4 · DOI · Paper page
  84. Haber, 2009, Peritoneal macrophage depletion by liposomal bisphosphonate attenuates endometriosis in the rat model, Hum Reprod., 24, 398, 10.1093/humrep/den375 · DOI · Paper page
  85. Chan, 2017, Co-culture with macrophages enhances the clonogenic and invasion activity of endometriotic stromal cells, Cell Prolif., 50, e12330, 10.1111/cpr.12330 · DOI · Paper page
  86. Mei, 2017, Immunosuppressive macrophages induced by IDO1 promote the growth of endometrial stromal cells in endometriosis, Mol Med Rep., 15, 2255, 10.3892/mmr.2017.6242 · DOI
  87. Shao, 2016, Macrophages promote the growth and invasion of endometrial stromal cells by downregulating IL-24 in endometriosis, Reproduction., 152, 673, 10.1530/REP-16-0278 · DOI
  88. McKinnon, 2012, Endometriosis-associated nerve fibers, peritoneal fluid cytokine concentrations, and pain in endometriotic lesions from different locations, Fertil Steril., 97, 373, 10.1016/j.fertnstert.2011.11.011 · DOI
  89. Tokushige, 2006, Nerve fibres in peritoneal endometriosis, Hum Reprod., 21, 3001, 10.1093/humrep/del260 · DOI · Paper page
  90. Tran, 2009, Macrophages and nerve fibres in peritoneal endometriosis, Hum Reprod., 24, 835, 10.1093/humrep/den483 · DOI · Paper page
  91. Cominelli, 2014, Matrix metalloproteinase-27 is expressed in CD163+/CD206+ M2 macrophages in the cycling human endometrium and in superficial endometriotic lesions, Mol Hum Reprod., 20, 767, 10.1093/molehr/gau034 · DOI
  92. Smith, 2012, Alternative activation of macrophages in rhesus macaques (Macaca mulatta) with endometriosis, Comp Med., 62, 303
  93. Strachan, 2013, CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8(+) T cells, Oncoimmunology., 2, e26968, 10.4161/onci.26968 · DOI · Paper page
  94. Gomez-Roca, 2019, Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages, Ann Oncol., 30, 1381, 10.1093/annonc/mdz163 · DOI · Paper page
  95. Ries, 2014, Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy, Cancer Cell., 25, 846, 10.1016/j.ccr.2014.05.016 · DOI · Paper page
  96. Nywening, 2016, Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial, Lancet Oncol., 17, 651, 10.1016/S1470-2045(16)00078-4 · DOI · Paper page

Cited by

See all 238

Metadata

Authors
Hogg, C., Horne, A. W., & Greaves, E.
Venue
Frontiers in Endocrinology
Published
2020-01-23
Volume
11
Pages
7-7
ISSN
1664-2392 (ISSN-L)
OpenAlex
W3001524003
Cited by
238
References
59
FWCI
20.61
Type
journal article
Language
en
Open access
gold
Funders
Medical Research Council

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.